P09945 (HIRV2_HIRME) Hirudo medicinalis (Medicinal leech)

Hirudin variant-2 UniProtKBInterProInteractive Modelling

72 aa; Sequence (Fasta)

Available Structures

115 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
THE STRUCTURE OF A COMPLEX OF RECOMBINANT HIRUDIN AND HUMAN ALPHA-THROMBIN
3htc
 Heteromer
P00734; 		8-72
Assess
THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX
4htc
 Heteromer
P00734; 		8-72
1×NAG;
Assess
Thrombin in complex with 3-chloro-benzamide
5afy
 Heteromer
P00734; 		61-72
2×NA; 1×WCE; 2×DMS; 1×PO4; 2×GOL; 1×NAG;
Assess
Thrombin in complex with 5-chlorothiophene-2-carboxamide
4ud9
 Heteromer
P00734; 		61-72
2×NA; 1×PO4; 2×DMS; 3×GOL; 2×EDO; 1×FQI; 1×NAG;
Assess
Thrombin in complex with 1-amidinopiperidine
4ue7
 Heteromer
P00734; 		61-72
1×IOD; 3×GOL; 2×NA; 1×PO4; 3×DMS; 1×EDO; 1×MRZ; 1×NAG;
Assess
Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(4-carbamimidoylbenzyl)pyrroli…
5jzy
 Heteromer
P00734; 		61-72
1×NAG; 3×DMS; 1×PO4; 2×NA; 1×6OV;
Assess
Thrombin Inhibition by Pyridin Derivatives
3qtv
 Heteromer
P00734; 		61-72
1×NAG; 1×06P; 1×PO4; 1×GOL; 2×NA;
Assess
Thrombin in complex with D-Phe-Pro-2-chlorofuran derivative (13l)
6zgo
 Heteromer
P00734; 		61-72
2×NA; 1×NAG; 3×DMS; 1×QKE;
Assess
Thrombin in complex with 1-(2R)-2-amino-3-phenyl-propanoyl-N-(2, 5dichlorophenyl)methylpyrrolidine-…
4udw
 Heteromer
P00734; 		62-72
2×NA; 1×N6L; 1×PO4; 1×GOL; 1×NAG;
Assess
Thrombin in complex with 4-Methoxy-N-(2-pyridinyl)benzamide
5af9
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 2×DMS; 1×SJR; 1×PO4; 3×GOL; 1×EDO;
Assess
Human Thrombin in complex with MI003
3rm2
 Heteromer
P00734; 		62-72
1×NAG; 1×S00; 1×PO4; 2×GOL; 2×NA;
Assess
Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine
5ahg
 Heteromer
P00734; 		62-72
2×NA; 2×DMS; 1×PO4; 1×GOL; 1×Y4L; 1×NAG;
Assess
Human thrombin complexed with fragment-based small molecules occupying the S1 pocket
2bvr
 Heteromer
P00734; 		61-71
1×4CP;
Assess
Human Thrombin In Complex With UBTHR104
3si4
 Heteromer
P00734; 		62-72
1×NAG; 1×B04; 1×PO4; 1×GOL; 2×NA;
Assess
Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2…
5mm6
 Heteromer
P00734; 		62-72
5×GOL; 2×DMS; 1×PO4; 2×NA; 1×32U;
Assess
Human Thrombin In Complex With UBTHR105
3sv2
 Heteromer
P00734; 		62-72
1×NAG; 1×P05; 1×PO4; 3×GOL; 2×NA;
Assess
Thrombin in complex with D-Phe-Pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c)
6yb6
 Heteromer
P00734; 		62-72
2×NA; 2×DMS; 1×NAG; 1×PO4; 1×PRO; 1×OJK;
Assess
Thrombin in complex with D-Phe-Pro-m-methoxybenzylamide derivative (16a)
6yhg
 Heteromer
P00734; 		62-72
1×PO4; 2×NA; 1×NAG; 1×GOL; 1×DPN; 1×PRO; 1×SZ4;
Assess
Thrombin in complex with MI2105
6rot
 Heteromer
P00734; 		62-72
1×KDQ; 1×NAG; 1×PO4; 3×DMS; 2×NA;
Assess
Human Thrombin in complex with MI354
3rm0
 Heteromer
P00734; 		62-72
1×NAG; 2×S54; 1×PO4; 1×GOL; 2×NA;
Assess
Thrombin in Complex with a D-Phe-Pro-p-benzylamine derivative
6t53
 Heteromer
P00734; 		62-72
2×NA; 2×DMS; 1×K73; 6×GOL; 1×PO4; 1×NAG;
Assess
Thrombin Inhibition by Pyridin Derivatives
3qx5
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 1×PO4; 1×GOL; 1×02P;
Assess
Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(5-chloro-2-(hydroxymethyl)ben…
5lce
 Heteromer
P00734; 		62-72
1×6TH; 1×NAG; 1×PO4; 1×DMS; 2×NA; 1×EDO; 3×GOL;
Assess
Thrombin in Complex with Methylbenzylamine
6t55
 Heteromer
P00734; 		62-72
2×NA; 1×02N; 1×PO4; 1×GOL; 1×NAG;
Assess
Thrombin Mutant A190S in complex with (S) -1 - ((R) -2-amino-3,3-diphenylpropanoyl) -N- (3-chlorobe…
5mjt
 Heteromer
P00734; 		62-72
1×23U; 1×DMS; 1×PO4; 5×GOL; 2×NA;
Assess
Human thrombin complexed with fragment-based small molecules occupying the S1 pocket
2bvs
 Heteromer
P00734; 		61-71
1×2CE;
Assess
Human Thrombin in complex with MI004
3rmo
 Heteromer
P00734; 		62-72
1×NAG; 1×S04; 2×GOL; 1×PO4; 2×NA;
Assess
Thrombin in complex with fragment J02
6i51
 Heteromer
P00734; 		62-72
1×NAG; 2×DMS; 1×PO4; 2×NA; 1×F05;
Assess
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54)
6ymp
 Heteromer
P00734; 		62-72
2×NA; 1×PO4; 1×NAG; 2×DMS; 1×D6Y;
Assess
Thrombin in complex with D-Phe-Pro-2-chlorothiophen derivative (16e)
6yhj
 Heteromer
P00734; 		62-72
1×EDO; 2×NA; 1×PO4; 1×NAG; 2×OQZ; 1×DMS;
Assess
Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94)
6yqv
 Heteromer
P00734; 		62-72
2×NA; 3×DMS; 1×PO4; 1×NAG; 1×8K2; 1×GOL;
Assess
Human Thrombin In Complex With MI001
3u98
 Heteromer
P00734; 		62-72
1×NAG; 1×BJA; 1×PO4; 2×NA;
Assess
Thrombin in complex with MI2100 ((S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-L-argin…
6gbw
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 2×DMS; 1×EU5;
Assess
Thrombin in Complex with a D-Phe-Pro-imidazole derivative
6t52
 Heteromer
P00734; 		62-72
2×NA; 1×PO4; 1×DMS; 1×MJH; 1×NAG;
Assess
Human Thrombin In Complex With MI340
3t5f
 Heteromer
P00734; 		62-72
1×NAG; 1×M34; 1×PO4; 3×GOL; 2×NA;
Assess
Thrombin in complex with (S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-D-arginyl)pyrro…
5jfd
 Heteromer
P00734; 		62-72
1×2TS; 1×NAG; 2×NA; 2×GOL; 1×DMS;
Assess
Thrombin in complex with 13k
6y02
 Heteromer
P00734; 		62-72
2×NA; 1×PO4; 2×DMS; 2×GOL; 1×O5Z; 1×NAG;
Assess
Thrombin in complex with D-Phe-Pro-m-Trifluoromethylbenzylamide derivative (phe2)
6y9h
 Heteromer
P00734; 		62-72
2×NA; 1×DMS; 2×PO4; 1×NAG;
Assess
Human Thrombin In Complex With MI353
3uwj
 Heteromer
P00734; 		62-72
1×NAG; 2×TIF; 1×PO4; 2×NA;
Assess
Thrombin in complex with (S)-1-((R)-2-amino-3-cyclohexylpropanoyl)-N-(2-(aminomethyl)-5-chlorobenzy…
5lpd
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 1×PO4; 1×GOL; 1×DMS; 1×71U;
Assess
Human Thrombin in complex with MI329
3rly
 Heteromer
P00734; 		62-72
1×NAG; 2×S29; 1×PO4; 1×GOL; 2×NA;
Assess
Human Thrombin In Complex With UBTHR97
3sha
 Heteromer
P00734; 		62-72
1×NAG; 1×P97; 1×PO4; 2×GOL; 2×NA;
Assess
Thrombin Inhibition by Pyridin Derivatives
3qto
 Heteromer
P00734; 		62-72
1×NAG; 1×10P; 1×GOL; 1×PO4; 2×NA;
Assess
Human Thrombin in complex with MI331
3rml
 Heteromer
P00734; 		62-72
1×NAG; 1×M31; 2×GOL; 1×PO4; 2×NA;
Assess
Thrombin in Complex with a D-DiPhe-Pro-p-pyridine derivative
6tdt
 Heteromer
P00734; 		62-72
1×PO4; 2×NA; 1×DMS; 1×LXW; 1×NAG;
Assess
Human Thrombin In Complex With UBTHR103
3si3
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 1×GOL; 1×PO4; 1×B03;
Assess
Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-…
4uff
 Heteromer
P00734; 		62-72
2×NA; 1×6V2; 1×PO4; 1×NAG;
Assess
Thrombin in Complex with a D-Phe-Pro-diaminopyridine derivative
6hsx
 Heteromer
P00734; 		62-72
2×DMS; 2×GOL; 2×NA; 1×NAG; 1×PO4; 1×GOZ;
Assess
Thrombin in Complex with a D-Phe-Pro-N-amidinopiperidine Derivative
6t57
 Heteromer
P00734; 		62-72
1×DMS; 1×PO4; 2×NA; 1×NAG; 1×J3I; 1×TFA;
Assess
Human Thrombin in complex with MI332
3rmm
 Heteromer
P00734; 		62-72
1×NAG; 1×M32; 2×GOL; 1×PO4; 2×NA;
Assess
Human Thrombin In Complex With MI330
3u9a
 Heteromer
P00734; 		62-72
1×NAG; 1×S33; 2×GOL; 1×PO4; 2×NA;
Assess
Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-…
4ufe
 Heteromer
P00734; 		62-72
2×NA; 1×3ZD; 1×PO4; 1×NAG;
Assess
Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((S)-1-((R)-3-cyclohexyl 2-((phenylmethyl…
6t8a
 Heteromer
P00734; 		62-72
1×MUZ; 1×NAG; 2×NA; 1×PO4; 2×DMS;
Assess
Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(3-chlorobenzyl)pyrrolidine-2-carbox…
5mls
 Heteromer
P00734; 		62-72
1×22U; 1×DMS; 1×PO4; 6×GOL; 2×NA;
Assess
Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-((1S)-2-((4- carbamimidoylphenyl)methylamin…
4ufg
 Heteromer
P00734; 		62-72
2×NA; 1×D6J; 1×PO4; 1×NAG;
Assess
Human Thrombin in complex with MI328
3rlw
 Heteromer
P00734; 		62-72
1×NAG; 1×S28; 1×PO4; 3×GOL; 2×NA;
Assess
Exploring thrombin S3 pocket
2zg0
 Heteromer
P00734; 		61-71
2×NA; 1×50U;
Assess
Thrombin Inhibition by Pyridin Derivatives
3qwc
 Heteromer
P00734; 		62-72
1×NAG; 2×NA; 1×GOL; 1×98P;
Assess
Human Thrombin in complex with MI341
3rmn
 Heteromer
P00734; 		62-72
1×NAG; 1×M41; 1×PO4; 2×GOL; 2×NA;
Assess
Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker
2bxt
 Heteromer
P00734; 		61-71
1×C2D;
Assess
Human Thrombin In Complex With UBTHR101
3shc
 Heteromer
P00734; 		61-71
1×NAG; 2×NA; 1×B01;
Assess
thrombin inhibitors
2c8w
 Heteromer
P00734; 		62-72
1×NA; 1×C7M;
Assess
Thrombin in complex with (S)-N-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-…
6t89
 Heteromer
P00734; 		62-72
1×MUQ; 1×NAG; 2×NA; 1×DMS;
Assess
2-(2-Chloro-6-Fluorophenyl)Acetamides as Potent Thrombin Inhibitors
2r2m
 Heteromer
P00734; 		62-72
1×I50;
Assess
thrombin inhibitors
2c8z
 Heteromer
P00734; 		62-72
1×NA; 1×DMS; 1×C2A;
Assess
thrombin inhibitors
2c8x
 Heteromer
P00734; 		62-72
2×DMS; 1×NA; 1×C5M;
Assess
thrombin inhibitors
2c8y
 Heteromer
P00734; 		62-72
3×DMS; 1×NA; 1×C3M;
Assess
thrombin inhibitors
2c93
 Heteromer
P00734; 		62-72
2×DMS; 1×NA; 1×C4M;
Assess
thrombin inhibitors
2c90
 Heteromer
P00734; 		62-72
1×DMS; 1×NA; 1×C1M;
Assess
Thrombin in complex with 3-amidinophenylalanine inhibitor
4e7r
 Heteromer
P00734; 		62-72
1×NAG; 1×0NW; 2×NA; 1×PO4; 2×GOL;
Assess
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to differe…
1tmu
 Heteromer
P00734; 		62-72
1×0G6; 1×NAG;
Assess
Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker
2bxu
 Heteromer
P00734; 		61-71
1×C1D;
Assess
Design and Discovery of Novel, Potent Thrombin Inhibitors with a Solubilizing Cationic P1-P2-Linker
2bvx
 Heteromer
P00734; 		61-71
1×5CB;
Assess
Thrombin in complex with benzamidine
4ueh
 Heteromer
P00734; 		63-72
1×NAG; 2×NA; 1×BEN; 1×PO4; 1×GOL;
Assess
Thrombin in Complex with a D-Phe-Pro-p-aminopyridine derivative
6t4a
 Heteromer
P00734; 		62-71
1×NAG; 1×J5K; 1×PO4; 1×GOL; 2×NA;
Assess
Thrombin in Complex with Benzylamine
6t56
 Heteromer
P00734; 		62-71
2×NA; 2×ABN; 1×GOL; 1×PO4; 1×NAG;
Assess
Thrombin in Complex with a D-Phe-Pro-2-aminopyridine derivative
6t3q
 Heteromer
P00734; 		62-71
1×NAG; 1×PO4; 1×GOL; 2×NA; 1×M6Q;
Assess
Thrombin in Complex with a D-Phe-Pro-p-phenol derivative
6t3m
 Heteromer
P00734; 		62-71
1×NAG; 2×MD8; 1×PO4; 2×NA;
Assess
Thrombin in complex with D-arginine (j77)
7ac9
 Heteromer
P00734; 		63-72
2×NA; 2×DMS; 1×PO4; 1×DAR; 1×NAG;
Assess
Thrombin Inhibitor
5a2m
 Heteromer
P00734; 		62-71
1×GOL; 2×NA; 1×WX5; 1×NAG;
Assess
Thrombin Inhibition by Pyridin Derivatives
3p17
 Heteromer
P00734; 		62-71
1×NAG; 1×99P; 1×PO4; 2×NA;
Assess
Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10)
6ysj
 Heteromer
P00734; 		62-71
2×NA; 2×DMS; 2×47A; 1×NAG;
Assess
Thrombin in complex with 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide (j80)
6ysx
 Heteromer
P00734; 		62-71
2×NA; 2×DMS; 1×PO4; 1×08D; 1×NAG;
Assess
Thrombin in complex with 4-hydroxybenzamide (j89)
6yn3
 Heteromer
P00734; 		62-71
1×PO4; 2×NA; 1×NAG; 2×DMS; 1×HBD;
Assess
Thrombin in Complex with a D-Phe-Pro-2-bromothiophene Derivative
6t54
 Heteromer
P00734; 		62-71
2×NA; 2×DMS; 1×GOL; 1×NAG; 1×MJK;
Assess
Alpha-thrombin complex with sulfated hirudin (residues 54-65) and L- Arginine template inhibitor CS…
1w7g
 Heteromer
P00734; 		62-71
1×MIU;
Assess
Crystal Structure Analysis of thrombin in complex with compound D57, 5-Chlorothiophene-2-carboxylic…
4loy
 Heteromer
P00734; 		62-71
1×NAG; 2×NA; 1×6XS;
Assess
Exploring thrombin S3 pocket
2zfq
 Heteromer
P00734; 		61-70
2×NA; 1×45U; 1×BEN; 1×GOL;
Assess
Human thrombin-in complex with UB-THR11
3biv
 Heteromer
P00734; 		62-71
1×NAG; 1×11U;
Assess
Exploring thrombin S3 pocket
2zfr
 Heteromer
P00734; 		61-70
2×NA; 1×46U; 1×GOL;
Assess
HUMAN THROMBIN-INHIBITOR COMPLEX
1k21
 Heteromer
P00734; 		62-71
1×NAG; 2×NA; 1×IGN;
Assess
Thrombin in complex with inhibitor
4bao
 Heteromer
P00734; 		62-71
1×NAG; 1×MVF; 2×NA;
Assess
HUMAN THROMBIN-INHIBITOR COMPLEX
1k22
 Heteromer
P00734; 		62-71
1×NAG; 2×NA; 1×MEL;
Assess
Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor
6eo8
 Heteromer
P00734; 		62-71
6×DMS; 1×2FN;
Assess
Exploring thrombin S3 pocket
2zhf
 Heteromer
P00734; 		62-71
2×NA; 1×49U; 1×GOL;
Assess
Exploring thrombin S3 pocket
2zhw
 Heteromer
P00734; 		62-71
2×NA; 1×12U;
Assess
HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1a5g
 Heteromer
P00734; 		62-71
2×NA; 1×00L;
Assess
HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1b5g
 Heteromer
P00734; 		62-71
1×0ZE; 2×NA;
Assess
Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA
1a2c
 Heteromer
P00734; 		62-71
1×NA;
Assess
Exploring thrombin S3 pocket
2zhe
 Heteromer
P00734; 		62-71
2×NA; 1×13U;
Assess
THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR
1a46
 Heteromer
P00734; 		62-71
2×NA; 1×00K;
Assess
Active site thrombin inhibitors
1wbg
 Heteromer
P00734; 		62-71
1×L03; 3×DMS;
Assess
THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR
1a61
 Heteromer
P00734; 		62-71
2×NA; 1×00N;
Assess
HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIA…
1tbz
 Heteromer
P00734; 		62-71
1×00Q; 2×NA;
Assess
MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMI…
1tmb
 Heteromer
P00734; 		62-71
Assess
Human thrombin-in complex with UB-THR10
3biu
 Heteromer
P00734; 		62-71
1×NAG; 2×NA; 1×10U;
Assess
ACTIVE SITE MIMETIC INHIBITION OF THROMBIN
3hat
 Heteromer
P00734; 		62-71
Assess
Thrombin in complex with (2R)-2-(benzylsulfonylamino)-N-(2-((4- carbamimidoylphenyl)methylamino)-2-…
5afz
 Heteromer
P00734; 		63-71
2×NA; 1×UET; 1×PO4; 1×NAG;
Assess
Thrombin Inhibition
3f68
 Heteromer
P00734; 		62-70
1×91U; 2×NA;
Assess
CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE
1a4w
 Heteromer
P00734; 		62-70
2×NA; 1×QWE;
Assess
CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXP…
1nrs
 Heteromer
P00734; 		62-70
Assess
Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor
6eo9
 Heteromer
P00734; 		63-70
6×DMS; 1×2OJ;
Assess
Complex of Recombinant Human Thrombin with a Designed Inhibitor
2cn0
 Heteromer
P00734; 		63-67
1×F25; 1×NA; 1×CA;
Assess
Thrombin in complex with 4-(((1-((2S)-1-((2R)-2-(benzylsulfonylamino)- 3-phenyl-propanoyl)pyrrolidi…
4ufd
 Heteromer
P00734; 		69-72
1×NAG; 2×NA; 2×GOL; 1×S49; 1×PO4;
Assess
Solution structural bundle of bivalirudin - a bivalent hirudin based thrombin inhibitor
8ef4
monomer53-71
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7a0e.1.Bmonomer0.738-71
83.08
Assess